Endocarditis guidelines: call for an interdisciplinary approach
Koch T, Hennigs A, Schmiedel S
LANCET INFECT DIS. 2024;24(2):e75.

Early neuroborreliosis with leg paresis mimicking herpes zoster
Tegtmeyer J, Abeck F, Matthews H, Christolouka M, Kött J, Schmiedel S, Schneider S, Koch T
J EUR ACAD DERMATOL. 2024;38(4):e329-e330.

Impfungen für neu- und wiederauftretende Viruserkrankungen
Weichel H, Koch T
INNERE MED. 2024;65(11):1082-1091.

Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Weskamm L, Tarnow P, Harms C, Huchon M, Raadsen M, Friedrich M, Rübenacker L, Grüttner C, Garcia M, Koch T, Becker S, Sutter G, Lhomme E, Haagmans B, Fathi A, Blois S, Dahlke C, Richert L, Addo M
ISCIENCE. 2024;27(8):110470.

Focussed Assessment with Sonography in acute Lassa Fever (FASLa): development of a point-of-care protocol and description of common ultrasound findings
Erameh C, Koch T, Edeawe O, Oestereich L, Omansen T, Jochum J, Adomeh D, Ikponwonsa O, Aire C, Pahlmann M, Asogun D, Ogbaini-Emovon E, Okogbenin S, Günther S, Ramharter M, Akideno P, Kreuels B
J INFECTION. 2023;87(1):27-33.

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022
Ettemeyer M, Florey M, Tanida K, Jochum J, Schulze-Sturm U, Lütgehetmann M, Baehr M, Addo M, Schmiedel S, Rohde H, Koch T
INFECTION. 2023;51(5):1569-1575.

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
Groger M, Akhideno P, Kleist C, Babatunde F, Edeawe O, Hinzmann J, Akhigbe T, Nwatuzor J, Eifediyi G, Müller J, Hinrichs M, Pahlmann M, Sarpong F, Wagner C, Thielebein A, Aihonwalan L, Koch T, Riedner M, Ogbaini-Emovon E, Okogbenin S, Günther S, Wicha S, Ramharter M, Oestereich L, Duraffour S, Erameh C
CLIN INFECT DIS. 2023;76(3):e841-e848.

Rationaler Umgang mit Antibiotika
Jochum J, Koch T
Hamb Ärztebl. 2023;77(11):13-16.

Penicillinallergie: Sicher und effektiv ausschließen
Koch T, Leubner H, Brehm T, Witte J
Deutsches Ärzteblatt. 2023;120(18):822-824.

Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability
Weimann L, Schäfer G, Matthews H, Florey M, Scheiter R, Hüfner A, Jordan S, Grenz M, Schmiedel S, Schulze Zur Wiesch J, Degen O, Koch T
JAIDS-J ACQ IMM DEF. 2023;93(1):e1-e3.

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Fathi A, Dahlke C, Krähling V, Kupke A, Okba N, Raadsen M, Heidepriem J, Müller M, Paris G, Lassen-Haartje S, Klüver M, Volz A, Koch T, Ly M, Friedrich M, Fux R, Tscherne A, Kalodimou G, Schmiedel S, Corman V, Hesterkamp T, Drosten C, Loeffler F, Haagmans B, Sutter G, Becker S, Addo M
NAT COMMUN. 2022;13(1):4182.

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik : Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
von Felden J, Brehm T, Schulze Zur Wiesch J, Addo M, Lohse A, Knobloch J, Koch T
BUNDESGESUNDHEITSBLA. 2022;65(3):398.

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
Weskamm L, Fathi A, Raadsen M, Mykytyn A, Koch T, Spohn M, Friedrich M, , Haagmans B, Becker S, Sutter G, Dahlke C, Addo M
CELL REP MED. 2022;3(7):.

Longitudinal development of antibody responses in covid-19 patients of different severity with elisa, peptide, and glycan arrays: An immunological case series
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco B, Ly M, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt N, Seeberger P, Addo M, Loeffler F
PATHOGENS. 2021;10(4):.

The COVID-19 Vaccine Landscape
Koch T, Fathi A, Addo M
ADV EXP MED BIOL. 2021;1318:549-573.

Correlates of Vaccine-Induced Protection against SARS-CoV-2
Koch T, Mellinghoff S, Shamsrizi P, Addo M, Dahlke C
VACCINES-BASEL. 2021;9(3):.

Less than you'd think-a prospective study on MRSA-colonization in healthy travellers
Tran D, Winter D, Christner M, Ramharter M, Addo M, Rolling T, Vinnemeier C, Koch T
J TRAVEL MED. 2021;28(3):.

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
von Felden J, Brehm T, Schulze-Zur-Wiesch J, Addo M, Lohse A, Knobloch J, Koch T
BUNDESGESUNDHEITSBLA. 2021;64(9):1165-1168.

Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
Dahlke C, Heidepriem J, Kobbe R, Santer R, Koch T, Fathi A, Ly M, Schmiedel S, Seeberger P, , Addo M, Loeffler F
medRxiv. 2020.

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria
Erameh C, Edeawe O, Akhideno P, Eifediyi G, Omansen T, Wagner C, Sarpong F, Koch T, Wicha S, Kurth F, Duraffour S, Oestereich L, Pahlmann M, Okogbenin S, Ogbaini-Emovon E, Günther S, Ramharter M, Groger M
BMJ OPEN. 2020;10(4):e036936.

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba N, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly M, Zinser M, Bartels E, Poetsch J, Neumann R, Fux R, Schmiedel S, Lohse A, Haagmans B, Sutter G, Becker S, Addo M
LANCET INFECT DIS. 2020;20(7):827-838.

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
Koch T, Rottstegge M, Ruibal P, Gomez-Medina S, Nelson E, Escudero-Pérez B, Pillny M, Ly M, Koundouno F, Bore J, Magassouba N, Dahlke C, Günther S, Carroll M, Addo M, Muñoz-Fontela C
VIRUSES-BASEL. 2020;12(9):.

Infektiologie und Tropendermatologie - Teil 58: Affenpocken bei Geflüchtetem?
Koch T, Rothe C
derm Praktische Dermatologie. 2016;2016(4):294.

Molecular Diagnosis of Human Taenia martis Eye Infection
Koch T, Schoen C, Muntau B, Addo M, Ostertag H, Wiechens B, Tappe D
AM J TROP MED HYG. 2016;94(5):1055-7.

Letzte Aktualisierung aus dem FIS: 20.12.2024 - 23:33 Uhr